BAP PHARMA Trademark

Trademark Overview

On Wednesday, August 28, 2024, a trademark application was filed for BAP PHARMA with the United States Patent and Trademark Office. The USPTO has given the BAP PHARMA trademark a serial number of 98721885. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, March 5, 2025. This trademark is owned by BAP Pharma Limited. The BAP PHARMA trademark is filed in the Advertising, Business and Retail Services, Transportation & Storage Services, and Computer & Software Services & Scientific Services categories with the following description:

Storage, transportation and distribution services; packaging services; packaging of pharmaceutical products; re-packaging services; re-packaging of pharmaceutical products; product labelling services; distribution services; distribution of pharmaceutical products and medical and scientific equipment; distribution of pharmaceutical products and medical and scientific equipment for use in clinical trials; cold chain storage, transportation and distribution services; cold chain storage, transportation and distribution of pharmaceutical products; cold chain storage, transportation and distribution of medical and scientific equipment

Business advisory services; business advisory services relating to supply chain management and the sourcing and procurement of goods and services; business advisory services relating to the manufacture, marketing and sale of pharmaceutical products; business advisory services relating to the operation of clinical trials; business advisory and support services concerning marketing authorisations and approvals for pharmaceutical products; business advisory services relating to the provision of bespoke medicines access programs; providing services for the procurement and management of randomisation lists in clinical trials; business consultancy services

Clinical trials services; conducting clinical trials for pharmaceutical products; design services; designing and planning clinical trials; packaging design services; design of product information booklets and leaflets; designing and generating randomisation lists for use in clinical trials; quality control services; certification (quality control) services; certification services concerning the importation of medicinal products; information, advisory and consultancy services relating to the aforesaid
bap pharma

General Information

Serial Number98721885
Word MarkBAP PHARMA
Filing DateWednesday, August 28, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, March 5, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesStorage, transportation and distribution services; packaging services; packaging of pharmaceutical products; re-packaging services; re-packaging of pharmaceutical products; product labelling services; distribution services; distribution of pharmaceutical products and medical and scientific equipment; distribution of pharmaceutical products and medical and scientific equipment for use in clinical trials; cold chain storage, transportation and distribution services; cold chain storage, transportation and distribution of pharmaceutical products; cold chain storage, transportation and distribution of medical and scientific equipment
Goods and ServicesBusiness advisory services; business advisory services relating to supply chain management and the sourcing and procurement of goods and services; business advisory services relating to the manufacture, marketing and sale of pharmaceutical products; business advisory services relating to the operation of clinical trials; business advisory and support services concerning marketing authorisations and approvals for pharmaceutical products; business advisory services relating to the provision of bespoke medicines access programs; providing services for the procurement and management of randomisation lists in clinical trials; business consultancy services
Goods and ServicesClinical trials services; conducting clinical trials for pharmaceutical products; design services; designing and planning clinical trials; packaging design services; design of product information booklets and leaflets; designing and generating randomisation lists for use in clinical trials; quality control services; certification (quality control) services; certification services concerning the importation of medicinal products; information, advisory and consultancy services relating to the aforesaid

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2024
Primary Code039
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBAP Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressBuckinghamshire SL71TB
GB

Trademark Events

Event DateEvent Description
Wednesday, August 28, 2024NEW APPLICATION ENTERED
Wednesday, October 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 9, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 4, 2025ASSIGNED TO EXAMINER
Wednesday, March 5, 2025NON-FINAL ACTION WRITTEN
Wednesday, March 5, 2025NON-FINAL ACTION E-MAILED
Wednesday, March 5, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 9, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

pharma services products pharmaceutical clinical trials advisory business distribution packaging relating